Global Epigenetics Market to Reach US$ 7.2 Billion by 2032, Driven by Increasing Prevalence of Chronic Ailments

June 05, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Epigenetics Market Report by Product (Reagents, Kits, Instruments, Enzymes, Services), Technology (DNA Methylation, Histone Methylation, Histone Acetylation, Large Non-Coding RNA, MicroRNA Modification, Chromatin Structures), Application (Oncology, Non-Oncology), and Region 2024-2032,” the global epigenetics market size reached US$ 2.4 Billion in 2023. Epigenetics refers to the study of cellular phenotype that does not include alterations in the underlying DNA sequence. It also refers to the dynamic modifications of the genome that can influence gene activity and function without changing the genetic code itself. Epigenetic modifications are pivotal in regulating gene expression patterns during development, cell differentiation, and in response to environmental stimuli. Epigenetic modifications can occur through various mechanisms, including DNA methylation, histone modifications, and non-coding RNA molecules. DNA methylation involves the addition of a methyl group to the DNA molecule, which can influence gene expression by inhibiting the binding of transcription factors and other regulatory proteins. Histone modifications, such as acetylation, methylation, phosphorylation, and ubiquitination, affect the structure and accessibility of DNA, thereby influencing gene activation or repression. Non-coding RNA molecules, such as microRNAs and long non-coding RNAs, can interact with messenger RNA (mRNA) to regulate gene expression at the post-transcriptional level. Epigenetic modifications can be influenced by various factors, including environmental exposures, lifestyle choices, and aging. At present, epigenetics is widely utilized for the diagnosis, monitoring, and treatment of oncological, autoimmune, metabolic, and cardiovascular disorders.

Global Epigenetics Market Trends:

The rising focus on epigenetic research and its potential applications represents one of the significant factors driving the growth of the market across the globe. This is primarily attributed to the increasing awareness and understanding of epigenetics modifications in various biological processes and diseases among researchers, clinicians, and the public, which is driving the growth of the market. In line with this, the increasing funding for research initiatives is contributing to the growth of the market. The market is also driven by the rising prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders. In addition to this, the increasing need for better diagnostic and therapeutic approaches for these diseases is fueling the demand for epigenetic research and technologies, which, in turn, is driving the growth of the market. Apart from this, the development of advanced tools and technologies for studying epigenetic modifications, such as DNA methylation, histone modification, and non-coding RNAs, is propelling the growth of the market. Moreover, high-throughput sequencing techniques, microarray platforms, and epigenome-editing technologies are improving the efficiency and accuracy of epigenetic analysis, thereby driving the growth of the market. Other factors, including the increased investment in the research and development (R&D) and collaborations between academia and industry, the rising shift toward personalized medicine aiming to tailor treatment strategies based on an individual's molecular profile, and the growing focus on incorporating epigenetic information into drug development and clinical practice, are creating a positive outlook for the market across the globe. Looking forward, the market value is projected to reach US$ 7.2 Billion by 2032, expanding at a CAGR of 12.6% during 2024-2032.

Market Summary:

  • On the basis of the product, the market has been divided into reagents, kits (chip sequencing, whole genomic amplification, bisulfite conversion, RNA sequencing, and other kits), instruments, enzymes, and services. Currently, kits account the largest market share across the globe.
  • Based on technology, the market has been classified into DNA methylation, histone methylation, histone acetylation, large non-coding RNA, microRNA modification, and chromatin structures. Presently, DNA methylation holds the largest market share across the globe.
  • On the basis of the application, the market has been bifurcated into oncology (solid and liquid tumors) and non-oncology (inflammatory, metabolic, infectious, cardiovascular, and other diseases). Currently, oncology is dominating the market across the globe.
  • On a geographical front, the market has been segmented into Asia Pacific, North America, Europe, Middle East and Africa, and Latin America. Presently, North America is dominating the market across the world.
  • The competitive landscape of the market has also been examined with some of the key players being Abcam plc, Active Motif Inc., Agilent Technologies Inc., Diagenode Diagnostics (Hologic Inc), Illumina Inc., Merck KGaA, PerkinElmer Inc., Roche Holding AG, Thermo Fisher Scientific Inc. and Zymo Research Corporation.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product, Technology, Application, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abcam plc, Active Motif Inc., Agilent Technologies Inc., Diagenode Diagnostics (Hologic Inc), Illumina Inc., Merck KGaA, PerkinElmer Inc., Roche Holding AG, Thermo Fisher Scientific Inc. and Zymo Research Corporation
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Epigenetics Market to Reach US$ 7.2 Billion by 2032, Driven by Increasing Prevalence of Chronic Ailments
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More